Limerick Post2h
Pharma company Eli Lilly signs €750,000 collaboration with Family Carers Ireland
A GLOBAL pharmaceutical company with a base in Limerick has signed a deal worth €750,000 to support the work of Family Carers ...
Investor's Business Daily on MSN3h
Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks
Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with a lot of ...
TMCnet4h
Weekly Roundup: 15 Health Press Releases You Need to See
A roundup of the most newsworthy healthcare announcements from PR Newswire this week, including the FDA's nicotine reduction ...
Citizen Tribune17h
FDA Approves Omvoh for Moderately to Severely Active Crohn Disease
The U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely ...
Hosted on MSN18h
Omvoh Approved for Crohn's; Fitbit Predicts IBD Flares; H. Pylori and Gastric Cancer
The FDA expanded the approval of mirikizumab (Omvoh) to include treatment of adults with moderately to severely active ...
STAT22h
FDA bans dye, curbs nicotine; study shows red meat associated with dementia risk
Rounds reports on the FDA banning red dye no. 3 and curbing nicotine levels; a study showing meat associated with dementia ...
Wockhardt’s ‘miracle drug’ Zaynich: Can it revive the antibiotics market and the company’s fortunes?
Wockhardt’s experimental drug, Zaynich, has shown impressive results, achieving a 100% cure rate in clinical trials for ...
Healio23h
IBD drug market rattles as Lilly’s Omvoh nabs FDA approval for second IL-23p19 in Crohn’s
The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...